NCT05087849 2025-10-02
Intralesional HPV Vaccine for Condylomata
University of California, San Francisco
Phase 1/2 Completed
Clinical Trials
26 trialsNCT00472459 2025-04-18
Photodynamic Therapy (PDT) With Metvix® 160 Milligrams/Gram Cream in Organ Transplant Participants With Non-melanoma Skin Cancer
Galderma R&D
Phase 3 Completed
NCT06214559 2025-03-05
Evaluate the Effectiveness and the Safety of a Medical Device in the Treatment of Common Warts and Plantar Warts.
Swiss Footcare Laboratories - Poderm Professional
Phase NA Completed
NCT03487549 2024-11-27
COVE-1
Verrica Pharmaceuticals Inc.
Phase 2 Completed
NCT03981822 2024-11-27
CARE-1
Verrica Pharmaceuticals Inc.
Phase 2 Completed
NCT04278573 2024-04-30
Intralesional Vitamin D Injection for Treatment of Common Warts
Mayo Clinic
Phase 2 Completed
NCT05070754 2024-04-05
Cold Atmospheric Plasma Device for Pediatric Molluscum and Verruca
Medical University of South Carolina
Phase 4 Completed
NCT04738734 2023-11-24
CellFX Comparison to Cryosurgery in Cutaneous Non-Genital Common Warts
Pulse Biosciences, Inc.
Phase NA Completed
NCT04554394 2023-07-27
CellFX System for the Treatment of Cutaneous Non-Genital Warts
Pulse Biosciences, Inc.
Phase NA Completed
NCT02231879 2023-04-07
Plerixafor Versus G-CSF in the Treatment of People With WHIM Syndrome
National Institutes of Health Clinical Center (CC)
Phase 2/3 Completed
NCT00973856 2023-01-31
Evaluation of the Effectiveness of an Alcohol Based Hand Gel for the Reduction of Warts on the Hands
Cleveland Clinic Akron General
Phase NA Completed
NCT04428359 2021-04-09
MMR
B.P. Koirala Institute of Health Sciences
Phase NA Completed
NCT01757392 2021-02-04
Candin Safety & Efficacy Study for the Treatment of Warts
Nielsen BioSciences, Inc.
Phase 2 Completed
NCT01101750 2021-01-05
Does the HPV Vaccine Cause the Same Response in Adolescent Kidney and Liver Transplant Patients as in Healthy Controls?
Medstar Health Research Institute
Phase 4 Completed
NCT03812510 2020-11-23
Safety Study of A-101 Topical Solution for the Treatment of Common Warts
Aclaris Therapeutics, Inc.
Phase 3 Completed
NCT03691831 2020-10-27
A Study of A-101 Topical Solution for the Treatment of Common Warts
Aclaris Therapeutics, Inc.
Phase 3 Completed
NCT03687372 2020-10-05
Study of A-101 Topical Solution for the Treatment of Common Warts
Aclaris Therapeutics, Inc.
Phase 3 Completed
NCT02650466 2019-08-06
Nanopulse Efficacy Study for the Treatment of Common Warts
University of Southern California
Phase NA Completed
NCT02393417 2019-06-04
Safety and Efficacy of Varying Regimens of CANDIN for Treatment of Common Warts (Verruca Vulgaris)
Nielsen BioSciences, Inc.
Phase 2 Completed
NCT01286441 2019-05-29
A Trial of a Botanical Drug Containing East Indian Sandalwood Oil (EISO) for Treatment of Common Warts
ViroXis Corporation
Phase 2 Completed
NCT03210337 2019-05-01
A Phase2 of A-101 Topical Solution in Subjects With Common Warts
Aclaris Therapeutics, Inc.
Phase 2 Completed
NCT03278028 2019-04-09
A Study of A-101 Topical Solution Administered Twice a Week in Subjects With Common Warts
Aclaris Therapeutics, Inc.
Phase 2 Completed
NCT02669862 2018-12-07
A Study of A-101 Solution in Subjects With Common Warts.
Aclaris Therapeutics, Inc.
Phase 2 Completed
NCT02622568 2017-09-08
Investigating Veregen â„¢ 15% Ointment Treatment For Non-facial Verrucae in Pediatric Patients: A Pilot Study
University of Texas Southwestern Medical Center
Phase 4 Completed
NCT00454181 2011-09-16
Treatment of Oral Warts in HIV+ Patients
Ainos, Inc. (f/k/a Amarillo Biosciences Inc.
Phase 2 Completed
NCT00569231 2011-01-25
Study With Candida Antigen for Treatment of Warts
University of Arkansas
Phase 1 Completed